SLC1A5 and central nervous system cancer: It has been demonstrated that high SLC1A5 expression has been correlated with poor prognosis in many cancers, including hepatocellular carcinoma [25], lung cancer [14], breast cancer [26], head and neck squamous cell carcinoma [27], glioma [28] and pancreatic adenocarcinoma [29].